Objective Patients with rheumatoid arthritis (RA), have an increased risk of fatal myocardial infarction (MI) that might be explained by an increased inflammatory burden of the heart. We investigated inflammatory cell density in heart tissue of deceased patients with RA and MI and compared them with controls with MI but without RA.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease and associated with an increased risk of developing myocardial infarction (MI) (1) (2) (3) . Moreover, an increased risk of fatality following MI has been reported in RA patients (4) . Remarkably, RA patients are less likely to report alarming symptoms, such as angina pectoris and more often experience an unrecognized MI or sudden cardiac death (5) .
Myocardial infarction occurs when the blood flow in the myocardium is diminished.
Progressive narrowing of the coronary artery lumen can induce oxygen deprivation in myocardial cells. Also coronary spasm can result in MI, albeit the main cause of sudden MI is plaque rupture with subsequent thrombus formation. Plaque rupture occurs mostly in atheromata with a thin and vulnerable fibrous cap (6, 7) .
The association between RA and MI can be explained by the concept that atherosclerosis is also an immune-mediated inflammatory disease, whereby large numbers of active immune cells, including macrophages and lymphocytes, are found in the atherosclerotic plaque that can produce inflammatory cytokines (8, 9) . To date, only one study has actually compared atherosclerotic plaques of coronary arteries in deceased RA patients with ageand sex-matched controls. This study revealed less multivessel disease, less severe grade of stenosis, but increased medial and adventitial inflammation and an increased frequency of vulnerable plaques in coronary arteries of RA patients compared to matched controls (10) . These findings suggest that RA patients, due to excess inflammation in the coronary artery wall, more often develop vulnerable plaques that are prone to rupture and cause MI. This might explain why RA patient more often experience MI. Unfortunately, they did not investigate which inflammatory cells were responsible for the excess inflammation.
Furthermore, the question why RA patients die more often due to sudden cardiac death is also not sufficiently answered. More and more evidence suggests that the intramyocardial vasculature can also play an important role in MI induction (11) . Baidoshvili et al. showed depositions of the advanced glycation end-product (AGE) carboxy-methyl lysine (CML) in the intramyocardial vasculature in advance of and subsequent to MI (12) . Notably, these depositions were independent of the epicardial vasculature. Moreover, in chronic inflammatory patients, including RA patients, dysfunction of the intramyocardial vasculature has been described independent of MI, although its pathophysiology is unknown (13) .
Post-MI, inflammation can induce additional cell death of cardiomyocytes, especially in the border area of the infarcted heart (14) . This is part of a process, called adverse remodeling, that can result in myocardial thinning, cardiomyocyte hypertrophy, apoptosis and extracellular matrix remodeling (15) . All these processes can, in time, facilitate heart failure development, a condition that is also highly prevalent in RA (16) .
To our knowledge, no studies have investigated the inflammatory process in the myocardium and intramyocardial arteries of RA patients. However, knowledge of the pathophysiologic mechanism behind the excess cardiovascular mortality and morbidity in RA would have important implications for the diagnostic and therapeutic approach in patients with chronic inflammatory diseases, like RA.
We hypothesize, that the systemic inflammatory process in RA, not only leads to inflamed epicardial coronary arteries resulting in vulnerable plaques, but also negatively affects the myocardial tissue and the intramyocardial arteries. Therefore, the purpose of the present study was to analyze the effect of RA in MI patients at different levels: 1) the inflammatory status of epicardial coronary arteries; 2) the inflammatory status of intramyocardial arteries; 3) inflammation of the heart post MI.
Methods

Subjects and design
This is a retrospective case-control autopsy study. From a post-mortem tissue database of subjects who underwent autopsy within 24 hours after death at the Department of Pathology, VU University Medical Centre (VUmc), Amsterdam, The Netherlands between January 1990 and December 2010, all subjects who were diagnosed with an acute MI at autopsy were selected. Diagnosis of RA was verified via the medical records and autopsy reports. The subjects with RA of which coronary and myocardial tissue was available were included in this study. For each of these subjects, five control subjects were selected. The control subjects (without RA) were also diagnosed with MI at autopsy and were matched for age, sex and year of death. Clinical data like hypertension, diabetes mellitus, hypercholesterolemia, history of cardiovascular disease and intensive care unit (ICU) admission, were also retrieved from the medical records. The present study was conducted in accordance with the Declaration of Helsinki and according to the guidelines of the ethics committee of the VUmc. The use of autopsy material after completion of the diagnostic process is part of the patient informed consent in the VUmc.
Tissue collection and analysis
Multiple sections of 5 µm thick were cut on a microtome from formalin-fixed and paraffinembedded tissue specimens of the left and right ventricle of the heart and the infarct related coronary artery (left anterior descending artery (LAD), left circumflex artery (LCX) or right coronary artery (RCA)) The infarct related coronary was cut at the point where the grade of stenosis was most severe. These sections were transferred with a drop of water onto glass slides, dried and stored for at least 24 hours before immunohistochemistry. Tissue specimens were also stained with hematoxylin-eosin and Elastica-von Gieson.
The myocardial tissue was taken from the infarct area (of the left ventricle, LV), its microscopically determined border area (also the LV) and the non-infarcted area (right ventricle, RV) of the heart of the same patient. Based on pre-defined criteria the myocardial infarct age was microscopically categorized into three phases: 1) early MI phase (death 3-12 hours after MI), 2) neutrophilic granulocyte MI phase (12 hours-5 days after MI) and 3) chronic MI phase (5-14 days after MI) (12) . Of each of the infarct-related coronary arteries, the grade of stenosis was calculated (lumen surface/lumen + intima surface, in percentage) and categorized into 4 groups: 0-25%, 25-50%, 50-75% and 75-100%. After matching for infarct related coronary artery, grade of stenosis and infarct phase of the original five controls per RA subject, only one best matching control, with MI but without RA was selected.
Immunohistochemistry
All tissue samples were stained for myeloperoxidase MPO (identifying neutrophilic granulocytes), CD45 (identifying lymphocytes), CD68 (identifying macrophages) and Tryptase (identifying mast cells). Myocardial tissue slides were also stained with the advanced glycation end-product N-epsilon-(Carboxymethyl)lysine (CML), a marker identifying pro-inflammatory status of the intramyocardial vasculature (17) .
Both myocardial tissue and coronary artery slides were deparaffinised in xylene for 10 minutes and transferred to 100% alcohol for 10 minutes. Thereafter, the slides were incubated in methanol/H 2 O 2 (0.3%) for 30 minutes to block endogenous peroxidases and afterwards rinsed with water. Antigen retrieval to unmask the antigenic epitope was performed, using a citrate buffer method (pH=6.0). Then all slides were heated to 100 ˚C for 5-6 minutes and 30 ˚C for 10 minutes and afterwards dried with a blower for 30 minutes. All slides were rinsed with phosphate buffered saline (PBS), and 100 µL of diluted antibody was added per slide for an hour, hereafter slides were rinsed with PBS and Envision was added for 30 minutes. The slides were again rinsed with PBS and stored in a dark room with PBS and diaminobenzidine (DAB) for 10 minutes.
In all slides, the number of CD45+, CD68+, Tryptase+ and MPO+ cells were determined by two investigators (AMS and IAMO). In the myocardial slides, the intramyocardial coronary arteries positive for CML were given an intensity score: 1=weak positivity; 2=moderate positivity; 3=strong positivity. The CML intensity score (1, 2, 3) was multiplied by the amount of intramyocardial coronary arteries positive for that score. Subsequently, the surfaces of the myocardial tissue slides and of the intima, media, adventitia and lumen of the coronary slides were measured, using a video overlay system, the Q-PRODIT 5. 
Statistical analysis
Differences between subjects with RA and controls were analysed using the nonparametric Mann Whitney U test. First, the differences between cell densities of all inflammatory cells combined (thus neutrophilic granulocytes + lymphocytes + macrophages + mast cells) of the infarct related epicardial coronary arteries of RA patients versus controls were analysed. Then, the cell densities of the four different inflammatory cell lines were analysed for the whole infarct related coronary artery.
Thereafter, the differences of the cell densities for the different layers (intima, media and adventitia) of the coronary arteries were statistically compared between the two groups.
The differences between RA patients and controls in cell densities (total inflammatory cell density and cell densities for the different inflammatory cells separately) and CML concentrations of the heart were analysed per infarct area, border area (both always left ventricle) and non-infarct area (always right ventricle).
Subject characteristics are presented as number and percentage, mean ± standard deviation or median + interquartile range (IQR) in case of a skewed distribution. Two sided p-values less than 0.05 were considered statistically significant. All analyses were performed by SPSS 19.0 (Chicago, IL, USA).
Results
Subject characteristics
In total, five subjects with RA and MI and five controls with MI but without RA were included in this study. The demographic characteristics, including data on cardiovascular risk factors and RA related factors are depicted in Table 1 . The characteristics of the infarct related epicardial coronary artery and heart tissue slides are presented in Table 2 .
The characteristics were not significantly different between RA patients and controls. 
Infarct related epicardial coronary artery
In total, 23 slides of the infarct related epicardial coronary artery were analysed: 12 of RA patients and 11 of controls. In the total vessel wall (combining the intimal, medial and adventitial layer) of the infarct related epicardial coronary artery of RA patients significantly more lymphocytes and mast cells were found compared to controls (Table 3 and Fig. 1 ).
When the analyses were performed for the intima, media and adventitia separately, except for a significantly lower cell density for neutrophilic granulocytes in the intima of RA patients, no other significant differences in inflammatory cell count in the intima and media were found in RA patients compared to controls. However, there was a significant increase of all inflammatory cells combined (lymphocytes, macrophages, neutrophilic granulocytes and mast cells) in the adventitia of RA patients compared to controls. In addition, in the adventitia the number of lymphocytes and mast cells was significantly higher in RA patients compared to controls. 
Figure 1 Cell densities of infarct related epicardial coronary arteries of rheumatoid arthritis (RA) patients versus controls
Results are shown as median and interquartile range, p<0.05 was considered significant. Immunohistochemical score / mm2
Heart tissue
The results of the analyses of the inflammatory cells within the heart tissue slides are depicted in fig. 3 .
In the infarct area of the heart, significantly more mast cells were found in RA patients compared to controls (3.4 IQR 2.4-4.1 vs. 2.1 IQR 1.4-2.7 cells/mm 2 , p<0.001). There were no significant differences in the number of neutrophils, lymphocytes and macrophages between RA patients and controls in the myocardium of the infarct area.
In the border area of the infarcted heart however, the numbers of lymphocytes and macrophages were significantly higher in the RA versus control group (15.6 IQR 9.9-20. 
cells/mm2
Discussion
Rheumatoid arthritis patients have an increased MI fatality rate compared to the general population. We hypothesized that this might be caused by increased inflammation at different levels, namely in the coronary artery (epicardial and intramyocardial) and the heart tissue. In this post-mortem study, we found: 1) significantly more lymphocytes and mast cells in the infarct related epicardial coronary artery, especially in the adventitial layer; 2) significantly more CML depositions in the intramyocardial vasculature of the infarct area, the border area and the non-infarcted area; 3) significantly more lymphocytes and macrophages in the border area of the infarcted heart of RA patients, who died after an MI compared to controls, who also died after an MI but had no RA.
Thus far, only a few studies have investigated the histologic features of coronary artery and heart tissue in RA patients and to our knowledge this is the first case-control study that analysed the inflammatory cell distribution of these tissues in patients with an autoimmune disease, as RA. Aubry et al. also looked at coronary tissue of RA patients with and without a history of cardiovascular disease and compared the histologic features, e.g.
grade of stenosis and plaque composition of coronary arteries with controls (10). However, they did not specify the inflammatory cells. When they analysed a subgroup of RA patients with a history of cardiovascular disease, they found less atherosclerosis but more plaque instability and inflammation, especially in the tunica media and adventitia of the epicardial coronary arteries in RA patients compared to controls. In our study we observed that especially lymphocytes and mast cells were more frequently present in RA patients than in controls. This increase was particularly evident in the tunica adventitia and to a lesser extent in the media, but not in the intima. It has been suggested that the adventitia functions as coordinator of the adaptive and innate immune response in atherosclerosis (18) . There is cumulating evidence that the adventitia communicates with the intima and plays a critical role in plaque development. In a study published in 1962, antigen-presenting cells and producers of cytokines and chemokines (20, 21) . Whether this is a systemic response, that can manifest in all arteries or only appears in the coronary arteries of RA patients remains to be investigated.
In the intramyocardial vasculature, we found a higher N-epsilon-(Carboxymethyl)lysine (CML) density in RA patients compared to the controls. CML is an advanced glycation end product (AGE) (22) . AGEs accumulate during aging and in diabetes patients accumulation of AGEs has been associated with vascular disease and increased oxidative stress (23, 24) .
Baidoshvili et al demonstrated CML accumulation in the intramyocardial vasculature in the hearts of patients with MI, compared to controls without MI (12) . It has been shown that CML is formed subsequent to MI and it has been suggested that CML is also present previous to a MI. Our findings now indicate that also the intramyocardial vasculature of MI patients with RA is more at risk of inflammation than that of MI patients without RA.
We also studied inflammation in the heart. The most striking differences were seen in the border area of the infarcted heart, where the macrophages and lymphocytes were present at a higher rate in RA patients versus controls. It is known that in the border area of the infarcted heart inflammation induces additional cell death of cardiomyocytes in time post-MI (25) . Interestingly, our findings now indicate that the inflammatory reaction in the border area of the infarcted heart is more pronounced in RA patients compared to controls, what could in part explain the worse outcome after an MI in RA patients compared to controls.
Our study indicates that RA patients encounter three important local risk factors in the heart that could play a role not only in MI induction, but also in heart failure development in time, namely: 1) increased inflammation in the adventitia of the infarct related epicardial coronary artery; 2) increased depositions of CML in the intramyocardial vasculature, and 3) increased inflammation of the heart, specifically the infarct border area. These findings could in part explain why heart failure is a very common health problem in RA patients (26) . It could also clarify why heart failure presents differently in RA patients compared to the general population (27) . However, unknown is the role of both factors in RA without MI, neither is their time frame of activation known, nor their functional aspects. This needs to be investigated in future studies and could perhaps lead to new therapeutical drugs to prevent heart failure and cardiac death in RA (28) .
We also found a higher presence of mast cells in the infarct area and the non-infarcted area of RA patients versus controls. It has been demonstrated that cardiac mast cell density increases following a myocardial infarction (29, 30) . Mast cells are believed to orchestrate the inflammatory reaction and are a dominant source of TNFα. They also play an important role in adverse remodelling (31) . However, despite the fact that the differences in mast cell density between RA patients and controls were significant, the differences were quite small and therefore it remains unclear if this finding is of clinical importance.
Because of the retrospective nature of this study and the small sample size, we were not able to correct for a possible difference in interventions that were performed or the medication given to treat the patient post MI. Furthermore, causal conclusions cannot be drawn. Notwithstanding, this study shows significant and meaningful differences between RA patients and controls. Nevertheless, these data need to be confirmed in future studies with larger sample sizes. However, this can only be realised by a multicentre approach or by using tissue samples from live patients, for example after a coronary artery bypass graft intervention.
When looking at the data from the RA group, there is a notable spreading of data compared to the control group. This could mean that not every RA patient has the same risk profile and specific disease characteristics, for example ACPA and rheumatoid factor positivity or cumulative inflammatory burden can also determine the inflammatory activity in the arteries and heart and thereby CV risk. Future pathology studies should try to determine which RA patient is especially prone for CV events and which therapy not only reduces disease activity but also the inflammatory process in the arteries and heart.
In conclusion, this study shows that the inflammatory status is increased in RA patients with MI at different levels, namely 1) in the adventitia of infarct related epicardial coronary arteries; 2) in the intramyocardial vasculature and 3) in the border area of the infarcted heart, compared with controls. These findings support the hypothesis that RA patients are prone to develop more vulnerable plaques due to more inflammation in the coronary arteries, but also develop more inflammation and thus more myocardial tissue damage after a myocardial infarction. This might not only explain the higher incidence of cardiovascular events in this population, but also the higher fatality rate after myocardial infarction.
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